chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Guillian Barre Syndrome - symptoms started 8/20/08 - diagnosed by MRI and lumbar puncture.  1/12/09 Reviewed hospital d/c summary for 8/26-9/1/2008 admission. FINAL DX: GBS; head concussion.  9/16/08 Reviewed hospital medical records of 8/26-9/1/2008.  FINAL DX: no discharge summary dictated Records reveal patient experienced progressive worsening of ascending weakness & heaviness of legs, tingling of feet, myalgias & HA since sports collision, difficulty walking, then tingling of hands, fatigue, weight loss, decreased appetite, intermittent nausea, abdominal pain, ataxia over 5-6 days prior to admit.  Seen by PCP when had continued dizziness & lower abdominal pain.  UA showed large amount of RBCs & sent for US.  Admit exam revealed areflexia of LEs & had abnormal gait, trouble lifting LEs.  Tx w/IVIG x 3 days.  Peds neuro, pulm  consult done.  Improved & d/c to home w/neuro & PCP f/u along w/EMG/NCS as outpatient.  9/12/08 Reviewed ER records of 8/23/2008. FINAL DX: s/p concussion syndrome w/no LOC, multiple contusions from sports collision. Records reveal patient experienced sports injury 5 days prior.  Had immediate HA but no LOC.  Dx w/concussion w/o LOC.  Returned to ER 8/23 after developed intermittent numbness in hands & had continued HA.  Had c-spine muscle tenderness & lower abdominal & CVA tenderness.  Also had intermittent leg heaviness & tingling in feet.  Neuro exam was completely WNL at that time.
Patient and daughter noticed erythema on L lower arm ~10 minutes after vaccine administration. Very minimal pruritus. Also noted some mild erythema above vaccine site on L shoulder. No edema noted, no SOB or dyspnea. Patient has experienced same reaction after previous vaccines. APRN administered 25 mg PO diphenhydramine at 1435. At 1440, redness is less evident now. At 1500, patient and daughter left vaccination facility in stable condition with erythema improved.
Patient recieved 2 doses of covid vaccine by pfizer.  Frist dose was on 1/15/21 (EL8982) and the next day patient was admitted for fever and altered mental status.  Spent one week in hospital.  Pt recieved the 2nd vaccine for covid on 2/5/21 (EL9265) and then spiked fever and readmitted the very next day for fever and altered mental status.  Noted to have a bullous rash over the injection site.
Pt describes receiving flu vax in one arm and pneumonia vax in other arm. Pt states flu hurt almost immediately post vax. Approximately 18:30, pain in arms was so severe that Motrin was ineffective. Pt complained of muscle cramps in legs that were never experienced prior to vax, fatigue even to stand, slept a lot, gasping for air a lot and low grade fever. Recovered as of 12/5/00.
Within minutes, before leaving the pediatrician's office, patient complained of "tongue hurting", began hyper-salivating and started to cough. He was brought back into the exam room, and his pulse Ox began to drop. He started losing color in his hands and lips, and started to lose consciousness. Dr. administered EpiPen Jr. and symptoms resolved immediately. He was then observed in the ED; on arrival (7 minutes) to local ED, he was covered in hives. This resolved with oral steroids, Benadryl; Zyrtec.
At 9:45 PM, foster mother notices child was shaking and stiff after arriving at store parking lot.  Foster mother removed child from car seat & ran into store. Requested 911 be called. Child was transported to hospital via ambulance.
This patient received V2V on 05/09/00. She was seen in the clinic on 05/18/00 with rash secondary to Varicella injection.
7 cm x 7 cm redness swollen. Hurt yesterday on hand notice today 7/16/10. Temp 99 degrees dizziness chills.
An 18 year old male patient presented to the physician's office on 05/15/2006 and prior to his vaccination with Adacel and Menomune he was found to have a fever of 102 degrees Fahrenheit, a red sore throat and throat ulcers. He was diagnosed with viral infection. He subsequently received his first intramuscular does of Adacel, lot number C2341AA, in the deltoid muscle and his first intramuscular dose of Menomune A/C/Y/W-135, lot number UE266AA in the deltoid muscle on 05/15/2006. The exact site of administration was not reported for either vaccine. Later that day, at an unspecified time, the patient developed abdominal wall weakness and weakness in his upper and lower extremities. It was reported that no diagnostic laboratory testing was completed. The next day the patient was evaluated by the physician and his symptoms had resolved. Follow-up information received on 15/Aug/2006 from a physician. The symptoms cleared on approximately 14/Aug/2006.
Redness, swelling and warmth from site which continued from time of the shot to the following day when she was seen. She received a Decadron 6mg IM.
difficult; joint pain in knees; joint pain in hips; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (difficult), ARTHRALGIA (joint pain in knees) and ARTHRALGIA (joint pain in hips) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CONDITION AGGRAVATED (difficult), ARTHRALGIA (joint pain in knees) and ARTHRALGIA (joint pain in hips). At the time of the report, CONDITION AGGRAVATED (difficult), ARTHRALGIA (joint pain in knees) and ARTHRALGIA (joint pain in hips) had not resolved.            No concomitant medications were reported.  No treatment medications were provided.
Information has been received from a registered nurse concerning a 10 year-old female patient with no known allergies who on 09-Oct-1997 was vaccinated in the left deltoid with a first dose of varicella virus vaccine live (Lot #623510/0694E). The registered nurse indicated the patient's mother reported that the patient has chicken pox with classic pustules on her trunk, which have been spreading for several days. It was noted the patient was not seen by the physician and there were not tests performed. The reporter noted, the patient is getting better at this point. Follow-up information received from the registered nurse reported the patient recovered with no problem. No other information is expected.
Parent, Father, reported child kept crying during the  night. Reported bumps on skin and worsening. No med given. Reported fever after vacciatnnion. P. Enc observe for signs of distress and to go to clinic. Enc. walk in for screening 07/25/13 to see MD. Enc TYLENOL for crying.
On 4/14, one week after my second Moderna shot, I experience swelling of the lymph nodes under my left arm/armpit area. It was painful and a bit freaky until I did some research that said that this is a side effect of the Moderna vaccine.  It is still painful and swollen today, 4/28/21, although definitely not as much as two weeks ago. I do believe it will be back to normal by next week, judging by how the swelling and pain have decreased.  I did get the same milder symptoms under my right arm/armpit but those are gone now.
Extreme hives all over body. Painful, hot, and itchy.  Extreme Dermagraphism.  Saw allergic and was put on steroid that only stopped hives for time on the medication.  Hives are back 2 days after and still extreme Dermagraphism.
Red blotchiness on both legs from the ankle to mid-calf.  No pain but tingling sensation when touched.
Persistent tension headache behind both eyes that started 5-6 days after vaccination and has lasted for >3 weeks after. This started after recovery from initial vaccine symptoms (slight fever, chills). This headache causes brain fog and I'm not able to work or focus. My right neck lymph node is slightly swollen as well, and there is pain when turning my neck.  Headache still persists. Will continue to monitor for symptoms of cerebral venous thrombosis (i.e. worsening headache) and visit a doctor.
This spontaneous report as received from a pharmacist refers to a patient of unknown demographics. No information about medical history concurrent conditions and concomitant medications was reported. The reporter stated that on 08-APR-2014 the patient was vaccinated with expired dose of ZOSTAVAX (lot number, expiration date unspecified) (dose, strength, indication route was not reported). No adverse effects reported. The outcome of received an expired dose of ZOSTAVAX is unknown. Additional information has been requested.
This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a 29-year-old male patient who received DTPa (Reduced antigen) (dTpa vaccine) for an unknown indication. On an unknown date, the patient received dTpa vaccine at an unknown dose. On an unknown date, unknown after receiving dTpa vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and whooping cough (serious criteria GSK medically significant). On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the whooping cough was recovered/resolved. It was unknown if the reporter considered the vaccination failure and whooping cough to be related to dTpa vaccine. Additional details were provided as follows: The age at vaccination was not reported. The whooping cough was resolved after 3 month. This case was considered to be a suspected vaccination failure case, as the details regarding laboratory confirmation for pertussis, vaccine schedule completion and exact time to onset were unknown.
This spontaneous report was received from a physician via an unspecified reporter referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 11-SEP-2015, the patient was vaccinated with a dose of improperly stored RECOMBIVAX HB 10 mcg/1 ml "10X1 DS/V TF" with lot number K002327 with expiration date 07-FEB-2016 (route of administration and anatomical location were not reported), which was stored at a lowest recorded temperature of 34 F (1.111111111 Celsius). The sum of hours in excursion was 512 hours. The vaccine status was reported as "in excursion", the storage criteria and the vaccine excursion were reported as "Refrigerator (R)".  No adverse effects were reported and no product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.
10/28 fully vaccinated.  Vaccine breaktrhough infection.  10/31  Inpatient admit to a med surg unit.
Large blood clot in right leg (with no risk factors - Very thin and healthy before receiving vaccine).  Urinary blockage and pain, inability to urinate leading to kidney issues  Severe confusion, disorientation, dizziness, brain fog, lack of appetite, stomach and back pain
Moderna COVID-19 Vaccine EAU A line of red spots along part of my arm  where the shot was given. Started  about 15 minutes after shot and is not going away.
Fever of 101.8.  1 tsp of Ibuprofen administered.  10 minutes later child started having a seizure that lasted over 30 minutes.
1st dose of the monovalent vaccine of the Moderna vaccine. For their second dose they received the monovalent Pfizer vaccine; Interchange of vaccine products; No adverse event; This spontaneous case was reported by a physician and describes the occurrence of COVID-19 IMMUNISATION (1st dose of the monovalent vaccine of the Moderna vaccine. For their second dose they received the monovalent Pfizer vaccine), INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and NO ADVERSE EVENT (No adverse event) in an 18-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    No medical history was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form and second dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 IMMUNISATION (1st dose of the monovalent vaccine of the Moderna vaccine. For their second dose they received the monovalent Pfizer vaccine), INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and NO ADVERSE EVENT (No adverse event). At the time of the report, COVID-19 IMMUNISATION (1st dose of the monovalent vaccine of the Moderna vaccine. For their second dose they received the monovalent Pfizer vaccine), INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for COVID-19 IMMUNISATION (1st dose of the monovalent vaccine of the Moderna vaccine. For their second dose they received the monovalent Pfizer vaccine) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products).    It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Concomitant medication not reported.   Treatment medication not reported.
NOTE:   Pharmacy received and gave 2020/2021 flu vaccine.  I was not given lot numbers or manufacturer.  1.  Two hours after shot, I had SLE rash and redness on my cheeks.  2. Within 4 hours after shot, I had hard, swollen red face tissue like hot frostbite near the SLE rash on my cheek. 3.  Within 24 hours after shot, my entire face was bright red, and my skin was clammy, but my temp stayed 98 F. 4.  I had painful headaches with pressure. 5.   Also within 24 hours, and for 2 days, I was vomiting and could not keep water or food down, and had some diarrhea.  I did NOT have any stomach pain, and had no other flu symptoms. 6.  Third Day after shot:   I woke up with pain in my right thigh that wouldn't go away, with a red rash that has been consistent in the past of x-rayed and diagnosed blood clots.  I again felt clammy and nauseated.  I treated with an extra aspirin, as my primary care was out today, and my Rheumatologist does not have time.  I was reluctant to go to ER for blood clot xray, as taking a chance on the blood clot was less of a threat than contracting COVID-19, given the spike in outbreaks.  Up through the day before the flu shot I had no symptoms and, as mentioned my immune system has been incredibly strong for the past 4 years.  I work full-time, and run 20 miles a week, including the night before the flu shot.  I have not had any of these symptoms for 4 years, before I was put on Plaquenil.  Because of the SLE rash, and red hard tissue 2 hours after the flu shot, and also because of the apparent blood clot, these are all indicators of a SLE flare-up for me that I have not had for 4 years.  Because of this, I believe that SLE, and APS secondary to SLE patients need to be cautioned on the flu virus.   There are about 100,000 SLE patients in this country, and 1/3 have APS secondary to SLE.  If those other SLE patients are not as healthy as I have been, if they have a SLE flare to the 2020/2021 flu vaccine like I did, they may have life-threatening organ damage/failure that would force them to seek ER.  If so, open beds is about nil right now.  Also, those other SLE (with APS) patients may not survive being in the hospital if they contract COVID-19 there.  It is also worth mentioning that I have never had a SLE flare with a flu shot before.  Although it may not matter, I also received a TB shot and booster 2/2020 with no adverse side affects.
Some allergic activity begins evening of vaccine received 8/27/12 continue through 9/10/12. Symptoms - itching, redness from site of injection down to elbow. Mild/moderate pain. Has no known allergy to vaccine components.
Red rash about 1 inch under injection site. Itchy, hot to touch, size of 2 nickels
Suspected vaccination failure; Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 2 months after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient received shingles shot and 2 months later the patient got the shingles. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.
He got a got blood clot; This is a spontaneous report from a contactable lawyer. This lawyer (patient's wife) reported for a male patient (reporter's husband) of an unspecified age received BNT162B2 (PFIZ-ER COVID-19 VACCINE, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient's medical history, concomitant medications and past drug therapy were not reported. The reporter husband had Pfizer vaccine and he got a blood clot. The outcome of the event was unknown.  The lot number for the vaccine was not provided and will be requested during follow up.
Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Medium, Systemic: Flushed / Sweating-Severe, Systemic: Nausea-Mild, Additional Details: Immediately after vaccine, the patient started to feel faint. He became very lethargic, light headed, and was sweating profusely. Patient also experienced nausea but no vomiting. I had him sit in head down position and gave him an ice pack and some water. Patient's wife also attended to him during this time. After about 20 minutes, he was able to get up and walk out of the store on his own.
The patient is a 49 y.o. female who reports onset of flu-like symptoms including headaches, intermittent fever, nausea and vomiting, and chills within 3 hours of receiving her first COVID-19 vaccination on 4/2/2021. She reports symptoms increased in intensity such that it required her to seek evaluation in the ER on 4/4/2021.  Patient states she was tested for COVID-19 and received positive results. She states she was diagnosed with viral pneumonia and COVID-19 and was discharged home. She received IV infusion therapy for the positive COVID-19 result on 4/7/2021, went home and took a nap and was awoken with severe chest pains and shortness of breath. She was taken to the ER via ambulance where she  was diagnosed with atrial flutter with rapid ventricular response and acute hypoxic respiratory failure secondary to COVID-19 infection. Patient was admitted to the hospital.
Throbbing arm, tingling finger advised to take Ibuprofen and ice arm and to call back if no better in 1-2 hours. Patient called next day because pain increased.
One day following measles vaccine, developed fever, diarrhea and vomiting at onset. Mother insists that we submit this report.
INSOMNIA; ENLARGED LYMPH NODES; BODY ACHES; FEVER; FATIGUE; HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced insomnia, enlarged lymph nodes, body aches, fever, fatigue, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, enlarged lymph nodes, fatigue, insomnia, body aches and headache was not reported. This report was non-serious.
Information has been received from a physician concerning a 13 year old female patient who was vaccinated with a dose of GARDASIL. The physician reported that patient developed pelvic inflammatory disease after being vaccinated with a dose of GARDASIL. It was unknown if the patient sought unspecified medical attention. The outcome was unknown. The physician reported that this is one of the two patient who experienced same adverse event. Additional information has been requested.
pt recvd vax & 10 hrs post inject pt devel muscle achiness that was treated w/APAP;
Pt. experienced slight swelling of (R) lip  spreading to (L) lip throughout the evening.  By morning of 10/2/2012 entire area around the mouth is noticeably swollen.  Some mouth soreness.  Pt. able to eat.  Feels the swelling is decreasing with time.  Did not call his PCP, although he was encouraged to do so.
rash, large blister, necrosis;RN found that pt had rxn approx 2wk p/vax;pt sent to clinic for eval;
Patient's third dose was given on 2/16/2022.  The 4th dose (2nd booster) was given less than 4 months after on 6/8/2022.
Shoulder was swollen half between neck and back; Right side of neck hurts when rotated to the right; Left arm was swollen to the tip of fingers and left leg still swollen to toes; Swelling appeared not only at the injection site; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 16Apr2021 at 15:15 (at the age of 72-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received typhoid vaccine (MANUFACTURER UNKNOWN) on an unknown date (when young) for unknown indication and experienced allergy to vaccine. On 16Apr2021 at 18:00, the patient experienced swelling that appeared not only at the injection site, but the shoulder was swollen half between neck and back. The patient's left arm was swollen to the tip of the fingers. At the time of reporting, the left leg was still swollen to the toes and the right side of the neck hurts when rotated to the right. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcomes of events shoulder was swollen half between neck and back, right side of neck hurts when rotated to the right, left arm was swollen to the tip of fingers and left leg still swollen to toes and swelling appeared not only at the injection site were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.